The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000277.2(PAH):c.441+1G>A

CA229545

102671 (ClinVar)

Gene: PAH
Condition: phenylketonuria
Inheritance Mode: Autosomal recessive inheritance
UUID: 19dc340b-f7df-4865-bba3-db4b17bddcab

HGVS expressions

NM_000277.2:c.441+1G>A
NM_000277.2(PAH):c.441+1G>A
NM_000277.1:c.441+1G>A
NM_001354304.1:c.441+1G>A
NM_000277.3:c.441+1G>A
NM_001354304.2:c.441+1G>A
ENST00000307000.7:c.426+1G>A
ENST00000549111.5:n.537+1G>A
ENST00000550978.6:n.426G>A
ENST00000551988.5:n.530+1G>A
ENST00000553106.5:c.441+1G>A
NC_000012.12:g.102877461C>T
CM000674.2:g.102877461C>T
NC_000012.11:g.103271239C>T
CM000674.1:g.103271239C>T
NC_000012.10:g.101795369C>T
NG_008690.1:g.45142G>A
NG_008690.2:g.85950G>A

Pathogenic

Met criteria codes 5
PVS1 PP4 PM2 PM3 PS3_Supporting

Evidence Links 4

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Phenylketonuria VCEP
The c.441+1G>A variant in PAH is a canonical splice variant in +1 splice site (exon 3/4 junction) in the canonical transcript of PAH, a gene fulfilling the most recent criteria for LOF being a known disease mechanism (PVS1; see PVS1: Recommendations for Interpreting the Loss of Function PVS1 ACMG/AMP Variant Criteria). In addition, the variant has been previously shown by RT-PCR analysis to alter RNA splicing (PS3_Supporting; PMID: 8535445). It is ultra-rare (highest observed population frequency 0.00001, with zero homozygotes, in gnomAD Non-Finnish European subpopulation), well under the PAH-specific frequency cutoff of 0.0002 (PM2). It has been found in multiple probands with classic PKU (e.g., PMID: 7726156, 8535445, 16256386, 17096675, 20187763, 22112818, 24350308, 23430918, 23764561, 8535445), although BH4 deficiency does not appear to have been formally excluded (PP4), including in trans with the Clinvar-Pathogenic R408W allele (PMID: 22112818) (PM3).
Met criteria codes
PVS1
Canonical splice variant in +1 splice site (exon 3/4 junction) in the canonical transcript of PAH, a gene fulfilling the most recent criteria for LOF being a known disease mechanism (see PVS1: Recommendations for Interpreting the Loss of Function PVS1 ACMG/AMP Variant Criteria).
PP4
Found in multiple probands with classic PKU, although BH4 deficiency does not appear to have been formally excluded.

PM2
Variant is ultra-rare (highest observed population frequency 0.00001, with zero homozygotes, in gnomAD Non-Finnish European subpopulation), well under the PAH-specific frequency cutoff of 0.0002.
PM3
PS3_Supporting
The variant has been previously shown by RT-PCR analysis to alter RNA splicing (PMID: 8535445)

Approved on: 2018-12-22
Published on: 2019-04-06
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.